The Impact of Body Mass Index and Metabolic Syndrome on Perioperative Outcomes Following Cervical Laminoplasty.

IF 3 3区 医学 Q2 CLINICAL NEUROLOGY
Ataollah Shahbandi, Pegah Ghamasaee, Abdul Mounnem Yassin Kassab, Saman Shabani
{"title":"The Impact of Body Mass Index and Metabolic Syndrome on Perioperative Outcomes Following Cervical Laminoplasty.","authors":"Ataollah Shahbandi, Pegah Ghamasaee, Abdul Mounnem Yassin Kassab, Saman Shabani","doi":"10.1177/21925682251349993","DOIUrl":null,"url":null,"abstract":"<p><p>Study DesignRetrospective cohort study.ObjectivesObesity and metabolic syndrome have become a common comorbidity among patients undergoing spine surgery. This study aimed to evaluate 30-day postoperative outcomes following cervical laminoplasty, stratified by BMI categories and the presence of metabolic syndrome.MethodsThis study utilized the 2007-2022 ACS-NSQIP database. Patients who underwent cervical laminoplasty were identified and categorized into six BMI groups, according to the World Health Organization guidelines, and based on the presence of metabolic syndrome. The primary outcome was the 30-day occurrence of at least one complication (excluding blood transfusions). Secondary outcomes included rates of complications, hospital length of stay, and total operative time.ResultsA total of 2261 patients were analyzed, including 21 underweight, 510 normal-weight, 782 pre-obese, 565 class I obese, 249 class II obese, and 134 class III obese individuals. The cohort consisted of only 244 individuals with metabolic syndrome. Class II obesity (coefficient 23.585, 95% CI 10.815-36.355; <i>P</i> < 0.001) and class III obesity (coefficient 20.096, 95% CI 4.712-35.479; <i>P</i> = 0.011) were independently associated with longer operative times. Metabolic syndrome was an independent risk factor for deep incisional SSI (OR 3.25, 95% CI 1.07-9.80, <i>P</i> = 0.037), postoperative pneumonia (OR 4.17, 95% CI 1.63-10.63, <i>P</i> = 0.003), and prolonged hospitalization (OR 1.68, 95% CI 1.17-2.41, <i>P</i> = 0.005).ConclusionsPatients with metabolic syndrome face an increased risk of adverse outcomes after cervical laminoplasty. Implementing preoperative preventive interventions may help mitigate complications and associated costs in these patients. Furthermore, preoperative weight loss in class II-III obese patients may help decrease operative time and associated costs.</p>","PeriodicalId":12680,"journal":{"name":"Global Spine Journal","volume":" ","pages":"21925682251349993"},"PeriodicalIF":3.0000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144038/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Spine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/21925682251349993","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study DesignRetrospective cohort study.ObjectivesObesity and metabolic syndrome have become a common comorbidity among patients undergoing spine surgery. This study aimed to evaluate 30-day postoperative outcomes following cervical laminoplasty, stratified by BMI categories and the presence of metabolic syndrome.MethodsThis study utilized the 2007-2022 ACS-NSQIP database. Patients who underwent cervical laminoplasty were identified and categorized into six BMI groups, according to the World Health Organization guidelines, and based on the presence of metabolic syndrome. The primary outcome was the 30-day occurrence of at least one complication (excluding blood transfusions). Secondary outcomes included rates of complications, hospital length of stay, and total operative time.ResultsA total of 2261 patients were analyzed, including 21 underweight, 510 normal-weight, 782 pre-obese, 565 class I obese, 249 class II obese, and 134 class III obese individuals. The cohort consisted of only 244 individuals with metabolic syndrome. Class II obesity (coefficient 23.585, 95% CI 10.815-36.355; P < 0.001) and class III obesity (coefficient 20.096, 95% CI 4.712-35.479; P = 0.011) were independently associated with longer operative times. Metabolic syndrome was an independent risk factor for deep incisional SSI (OR 3.25, 95% CI 1.07-9.80, P = 0.037), postoperative pneumonia (OR 4.17, 95% CI 1.63-10.63, P = 0.003), and prolonged hospitalization (OR 1.68, 95% CI 1.17-2.41, P = 0.005).ConclusionsPatients with metabolic syndrome face an increased risk of adverse outcomes after cervical laminoplasty. Implementing preoperative preventive interventions may help mitigate complications and associated costs in these patients. Furthermore, preoperative weight loss in class II-III obese patients may help decrease operative time and associated costs.

体重指数和代谢综合征对颈椎椎板成形术围手术期疗效的影响。
研究设计回顾性队列研究。目的肥胖和代谢综合征已成为脊柱手术患者的常见合并症。本研究旨在评估颈椎椎板成形术后30天的术后结果,根据BMI分类和代谢综合征的存在进行分层。方法本研究采用2007-2022 ACS-NSQIP数据库。根据世界卫生组织(World Health Organization)的指南,并根据代谢综合征的存在,对接受颈椎椎板成形术的患者进行了鉴定,并将其分为六个BMI组。主要终点是30天内发生至少一种并发症(不包括输血)。次要结局包括并发症发生率、住院时间和总手术时间。结果共分析2261例患者,其中体重不足21例,体重正常510例,肥胖前期782例,I级肥胖565例,II级肥胖249例,III级肥胖134例。该队列仅包括244名代谢综合征患者。II类肥胖(系数23.585,95% CI 10.815-36.355;P < 0.001)和III类肥胖(系数20.096,95% CI 4.712-35.479;P = 0.011)与较长的手术时间独立相关。代谢综合征是深切口SSI (OR 3.25, 95% CI 1.07-9.80, P = 0.037)、术后肺炎(OR 4.17, 95% CI 1.63-10.63, P = 0.003)和住院时间延长(OR 1.68, 95% CI 1.17-2.41, P = 0.005)的独立危险因素。结论代谢综合征患者在颈椎椎板成形术后出现不良后果的风险增加。实施术前预防性干预可能有助于减轻这些患者的并发症和相关费用。此外,II-III级肥胖患者术前减重可能有助于减少手术时间和相关费用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Global Spine Journal
Global Spine Journal Medicine-Surgery
CiteScore
6.20
自引率
8.30%
发文量
278
审稿时长
8 weeks
期刊介绍: Global Spine Journal (GSJ) is the official scientific publication of AOSpine. A peer-reviewed, open access journal, devoted to the study and treatment of spinal disorders, including diagnosis, operative and non-operative treatment options, surgical techniques, and emerging research and clinical developments.GSJ is indexed in PubMedCentral, SCOPUS, and Emerging Sources Citation Index (ESCI).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信